Zoom Ventures Backs Medaica to Move Physical Exams Into Telehealth

Zoom Ventures has made a strategic investment in Medaica, a medical intelligence company whose Telehealth 2.0 platform aims to bring FDA-cleared remote examinations, medical devices and AI-assisted diagnostics into virtual appointments. The companies did not disclose the amount.

The deal matters because telehealth still has a structural gap: doctors can see patients on video, but they can't examine them. Conventional video consultations can't replace the physical exams traditionally performed in clinics, which often forces patients to book extra in-person visits for measurements, diagnostics or monitoring. Medaica is building technology to close that gap.

What does Medaica's technology actually do?

Medaica's existing FDA-cleared technology lets clinicians perform real-time remote heart and lung assessments. The core capability is remote auscultation — the clinical technique of listening to internal body sounds produced by the heart and lungs.

The Telehealth 2.0 platform is designed to go further. It connects medical devices with virtual care environments, so clinicians can examine and monitor patients in real time from a distance. The broader roadmap includes:

• Integration of additional diagnostic tools and medical devices
• Support for third-party applications
• AI-assisted analysis to help interpret information collected during remote exams
• Clinical decision-support tools

The companies are clear on one boundary: clinical decisions remain the responsibility of qualified healthcare professionals. The AI assists; it doesn't decide.

Who benefits first?

Patients who struggle to travel are the clearest near-term use case. Older adults, people with mobility limitations and rural patients face the biggest barriers to in-person care. Remote examination could cut unnecessary travel and allow more frequent monitoring of certain conditions — particularly cardiovascular and respiratory illnesses that require ongoing assessment. Care facilities are another target, where residents could get specialist evaluations without being transported to outside medical offices.

Dr. Byron Williams Jr., Emeritus Chief of Medicine at Emory University Hospital Midtown and Chief of Cardiology at Emory Saint Joseph's, has used the technology in practice. "Medaica's solution enabled me to monitor my patients' murmurs and bruits remotely in real time. That was liberating not only for us, but for my patients, some of whom are in their 90s and live more than an hour from the clinic," he said. Bruits are abnormal vascular sounds clinicians evaluate when assessing blood flow. "This technology can significantly expand the care that can be delivered remotely," Williams added.

Why is Zoom writing the check?

The investment extends Zoom's healthcare strategy beyond communications software. Zoom already supplies collaboration technology to businesses and healthcare organizations, and Medaica's platform complements — rather than replaces — those existing telehealth experiences. Abhisht Arora, Zoom's Chief Strategy Officer, framed the deal as a natural extension.

"Zoom's investment in Medaica is an extension of our longstanding commitment to connecting clinicians, patients, and staff, regardless of location, and equipping them with tools that enhance care and reduce the administrative burden," Arora said. "Medaica enhances care from anywhere, establishing digital-first clinical examinations as a new standard for accessible, high-value, and on-demand healthcare delivery."

The CEO's bet

Medaica CEO and co-founder Stephen Randall sees the deal as a way to build out an ecosystem that goes well beyond video visits.

"Telehealth transformed access to healthcare, but the physical exam remained in the clinic. Telehealth 2.0 will enable clinicians to examine, detect, diagnose, and monitor patients remotely in real time," Randall said. "With Zoom's investment, we are building an ecosystem of medical devices, AI and diagnostic tools that can bring clinical examinations to every home and care facility."

What does this change for practitioners?

For clinicians, the pitch is straightforward: more diagnostic information during remote encounters, covering workflows from examination and measurement to monitoring and clinical assessment. The investment is intended to accelerate platform development and push remote examination technology into mainstream virtual care workflows.

If Medaica delivers, the model it's chasing is a virtual appointment that incorporates much of what patients currently get only in person — an outcome that would reshape how care gets delivered in homes and care facilities alike.